[go: up one dir, main page]

ES2039255T3 - Utilizacion de n-((1-etil-2-pirrolidinil)metil)-2-metoxi-5-sulfamoil-benzamida en el tratamiento de la esterilidad. - Google Patents

Utilizacion de n-((1-etil-2-pirrolidinil)metil)-2-metoxi-5-sulfamoil-benzamida en el tratamiento de la esterilidad.

Info

Publication number
ES2039255T3
ES2039255T3 ES198787401496T ES87401496T ES2039255T3 ES 2039255 T3 ES2039255 T3 ES 2039255T3 ES 198787401496 T ES198787401496 T ES 198787401496T ES 87401496 T ES87401496 T ES 87401496T ES 2039255 T3 ES2039255 T3 ES 2039255T3
Authority
ES
Spain
Prior art keywords
sterility
treatment
benzamide
pirrolidinil
sulfamoil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198787401496T
Other languages
English (en)
Inventor
Pr. Peter William Howie
M. Alan Mcneilly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Original Assignee
Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dEtudes Scientifiques et Industrielles de lIle de France SA filed Critical Societe dEtudes Scientifiques et Industrielles de lIle de France SA
Application granted granted Critical
Publication of ES2039255T3 publication Critical patent/ES2039255T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

EL PRESENTE INVENTO CONCIERNE A LA UTILIZACION DEL N-[(1-ETIL-2-PIRRODINIL) METIL] 2-METOXI 5-SULFAMOIL BENZAMIDA, PARA LA PREPARACION DE UN MEDICAMENTO PARA EL TRATAMIENTO DE LA ESTERILIDAD
ES198787401496T 1987-06-30 1987-06-30 Utilizacion de n-((1-etil-2-pirrolidinil)metil)-2-metoxi-5-sulfamoil-benzamida en el tratamiento de la esterilidad. Expired - Lifetime ES2039255T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87401496A EP0297191B1 (fr) 1987-06-30 1987-06-30 Application du N-[(1-éthyl 2-pyrrolidinyl) méthyl] 2-méthoxy 5-sulfamoyl benzamide au traitement de la stérilité

Publications (1)

Publication Number Publication Date
ES2039255T3 true ES2039255T3 (es) 1993-09-16

Family

ID=8198226

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198787401496T Expired - Lifetime ES2039255T3 (es) 1987-06-30 1987-06-30 Utilizacion de n-((1-etil-2-pirrolidinil)metil)-2-metoxi-5-sulfamoil-benzamida en el tratamiento de la esterilidad.

Country Status (5)

Country Link
EP (1) EP0297191B1 (es)
AT (1) ATE66811T1 (es)
DE (1) DE3772764D1 (es)
ES (1) ES2039255T3 (es)
GR (1) GR3003065T3 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6224895B1 (en) 1996-12-18 2001-05-01 Clemson University Method for promoting ovulation, parturition, and lactation in mammals
US6534526B2 (en) 2001-07-16 2003-03-18 Clemson University Laminitis in horses

Also Published As

Publication number Publication date
GR3003065T3 (en) 1993-02-17
ATE66811T1 (de) 1991-09-15
DE3772764D1 (de) 1991-10-10
EP0297191B1 (fr) 1991-09-04
EP0297191A1 (fr) 1989-01-04

Similar Documents

Publication Publication Date Title
ATE69376T1 (de) Haarwuchsmittel.
FI872917A0 (fi) Farmaceutiska baerare, vilka frigoer aktivaemnet reglerbart.
NO870241L (no) Hypoglykemiske tiazolidindioner.
FI881103A0 (fi) Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi
NO890259D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
NO943521L (no) Anvendelse av et pyrrolidinacetamidderivat for fremstilling av et terapeutikum
IT9041529A0 (it) Dispositivo per la correzione chirurgica dell'ametropia
SE8600017L (sv) Ny forening
IT1238803B (it) Dispositivo per la cura chirurgica dell'ametropia
IL87566A0 (en) Medical composition for the treatment of diabetes comprising a benzamide derivative
ES2108680T3 (es) Uso del derivado n-n-butilo de desoxinojirimicina en la fabricacion de un medicamento.
ES2039255T3 (es) Utilizacion de n-((1-etil-2-pirrolidinil)metil)-2-metoxi-5-sulfamoil-benzamida en el tratamiento de la esterilidad.
ES2094757T3 (es) Un factor megacariocitopoyetico.
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
NO890245D0 (no) Isoxazoler med nootrop aktivitet.
DK48489A (da) Heteroanellerede phenylglycin-beta-lactam-antibiotika og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
DE3877499D1 (de) 2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.
ES2032203T3 (es) Procedimiento de preparacion de derivados del 5-(2-1-pirrolidinil)p-cimeno.
IT1229511B (it) Dispositivo per la cura chirurgica dell'astigmatismo